Objective To examine the development of age-related maculopathy (ARM) in a large-scale
trial of low-dose aspirin treatment. Methods The Physicians' Health Study I was a …

Context Aspirin is widely used for relief of pain and for cardioprotective effects. Its use is of
concern to ophthalmologists when ocular surgery is being considered and also in the …

OBJECTIVE: To test whether alternate-day low-dose aspirin affects incidence of age-related
macular degeneration (AMD) in a large-scale randomized trial of women. DESIGN …

• Observational studies have raised the question of a possible benefit of aspirin on the
development of cataract. The Physicians' Health Study, a randomized double-masked …

Background In Physicians' Health Study I, randomized trial results indicated no major
beneficial effect of 5 years of low-dose aspirin treatment on total cataract (relative risk [RR] …

Objective To determine whether regular aspirin use is associated with a higher risk for
developing age-related macular degeneration (AMD) by using analyzed data from a 15-year …

What is known and objectives Aspirin is one of the most widely used medications in the
world. The evidence on its effect on the risk of age‐related macular degeneration (AMD) …

PURPOSE: To examine whether low-dose aspirin (325 mg on alternate days) reduces the
risk of age-related cataract and subtypes. This report extends previous findings, including …

Introduction: Aspirin is used regularly for rheumatoid pain management and
cardioprotection. However, aspirin has also been associated with significant adverse events …

The possible role of aspirin in slowing cataract formation has been discussed both in the lay
pressl and in trade publications widely distributed to ophthalmologists. 2 Existing data are …